Chinese chipmaker Iluvatar CoreX plans to raise $800 million in Hong Kong

Shanghai-based company Iluvatar CoreX Semiconductor is considering an additional public offering in Hong Kong to raise at least $800 million — Bloomberg sources familiar with the company's plans reported on July 8, 2026. Since its initial public offering in January 2026, the company's share price has surged 428%.

Why Does Iluvatar CoreX Need Another $800 Million?

An additional stock offering allows the company to convert stock market success into real capital. When shares trade 428% above the IPO price, each new share generates significantly more money with less dilution of existing shareholders — which is precisely why such deals often follow sharp increases in valuations.

The proceeds are expected to be directed toward expanding manufacturing capacity and accelerating the development of new chips. The AI accelerator market requires massive investments: from architectural design to scaling production volumes and building robust supply chains. In a sector where dozens of players compete and product cycles have compressed to 12–18 months, falling behind in funding quickly translates to falling behind in development.

Key parameters of the proposed offering:

• Minimum volume — $800 million
• Platform — Hong Kong Stock Exchange
• Share growth since IPO — 428% (January–July 2026)
• Status — under consideration, according to Bloomberg

What

Is Iluvatar CoreX and Why Do Investors Believe in the Company?

Iluvatar CoreX Semiconductor is a Shanghai-based company specializing in developing semiconductors for AI computing. It went public on the Hong Kong Stock Exchange in January 2026 and has since become one of the most impressive growth stories among regional technology IPOs.

Behind the sharp rise in valuations lies structural demand. U.S. restrictions on exporting advanced GPUs to China force local companies — technology giants, cloud providers, and government bodies — to seek domestic alternatives. Manufacturers like Iluvatar CoreX find themselves in a favorable position: they offer AI chips that Chinese corporations can purchase without sanctions risk and logistics disruptions. This creates sustained demand from both end buyers and financial investors betting on this market's growth.

The Hong Kong Exchange remains the preferred platform for Chinese technology companies targeting international capital: it provides access to global investors combined with a relatively clear legal environment. In recent years, it has hosted the largest offerings by Chinese technology companies.

What Do Existing Shareholders Risk?

Any additional offering carries a technical dilution effect: new shares entering the market create short-term downward pressure on valuations. This is why even companies with strong momentum often see temporary corrections after announcing secondary offerings — the market prices in potential dilution ahead of time.

However, for companies with high growth rates and strong operational momentum, the market often perceives secondary offerings positively in the medium term: fresh capital accelerates development and strengthens market positions.

An important caveat from Bloomberg: the deal is not yet finalized. Sources describe it as "under consideration" rather than confirmed plans. Negotiations at this level typically take several months, and the final parameters — volume, structure, and timing — often differ significantly from initial discussions.

What This Means

Iluvatar CoreX's 428% growth and potential $800 million raise reflect a broader trend: investors are actively betting on Chinese AI infrastructure manufacturers developing independently from U.S. suppliers. If the offering proceeds, the company will significantly strengthen its financial foundation to compete in the race among AI chipmakers and cement its status as a key player in the industry.